FirmaIQ
Org.nr 918 832 424 2018 → 2019 Year-over-year analysis

ABIOSA PHARMA AS: årsregnskap 2019 vs 2018

Shrank 100% on revenue, slipped into loss

approved 2020-08-19; registry 2020-09-02; journal 2020 765992

Full company analysis · All year comparisons

Summary

What changed

Comparing Årsregnskap 2019 with 2018 for ABIOSA PHARMA AS. Revenue 1 194 NOK → 0 NOK (-100.0%). Net result +22.2k NOK → -971 NOK. Equity -7 315 NOK → -8 286 NOK.

On the constructive side: operating result improved. Pressures included: revenue fell; fell into a net loss.

Also worth watching: thin equity buffer. All figures are taken from the published annual accounts for ABIOSA PHARMA AS.

At a glance

Scorecard

Revenue
1 194 NOK 0 NOK
-100.0%
Operating result
-22.2k NOK -975 NOK
+95.6%
Net result
+22.2k NOK -971 NOK
-104.4%
Equity
-7 315 NOK -8 286 NOK
-13.3%
Cash
9 048 NOK 8 077 NOK
-10.7%
Total assets
9 048 NOK 77 NOK
-99.1%

What improved

  • ↑

    Operating result improved

    Operating result -22.2k NOK → -975 NOK. Calculated

What deteriorated

  • ↓

    Revenue fell

    Operating income / revenue moved from 1 194 NOK to 0 NOK (-100.0% YoY). Calculated

  • ↓

    Fell into a net loss

    Net result flipped from 22.2k NOK profit to a loss of 971 NOK. Calculated

Things to notice

  • ·

    Thin equity buffer

    Equity ratio is -10761.0% of assets — limited loss-absorbing capacity on a stand-alone basis. Interpretation